Nides, Mitchell <br/><br/>
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.  [electronic resource] 

 -  Archives of internal medicine   
 - 1561-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-9926 
<br/><br/><label>Standard No.: </label>10.1001/archinte.166.15.1561  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Benzazepines--adverse effects<br/>Bupropion--therapeutic use<br/>Dopamine Uptake Inhibitors--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Health Status<br/>Humans<br/>Male<br/>Middle Aged<br/>Nicotinic Agonists--adverse effects<br/>Nicotinic Antagonists--adverse effects<br/>Quinoxalines--adverse effects<br/>Smoking Cessation--methods<br/>Tobacco Use Disorder--drug therapy<br/>Treatment Outcome<br/>Varenicline